A Chinese company is already mass producing Gilead's experimental coronavirus drug
In a highly unusual step, a Chinese company said it has begun mass producing an experimental Gilead drug that US doctors used to treat patients infected with the novel coronavirus.
BrightGene Bio-Medical Technology Co said in a filing to the Shanghai stock exchange that it developed technology to manufacture remdesivir and began mass producing the active pharmaceutical ingredient for the event the drug is approved by Chinese authorities while the outbreak is ongoing. They said they are in the process of making the full drug.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
